Am. J. Respir. Crit. Care Med., Volume 161, Number 2, February 2000, 636-640

Prostaglandin H Synthase 2 Expression in Airway Cells from Patients with Asthma and Chronic Obstructive Pulmonary Disease

RAME TAHA, RON OLIVENSTEIN, TOMOKI UTSUMI, PIERRE ERNST, PETER J. BARNES, IAN W. RODGER, and ADEL GIAID

Departments of Medicine and Pathology, Montreal General Hospital, and Montreal Chest Hospital, McGill University, Montreal, Quebec, Canada; National Heart and Lung Institute, London, United Kingdom; and Merck Frosst Canada, Inc., Montreal, Quebec, Canada

Products of the prostaglandin H synthase (PGHS) metabolic pathway are thought to play a role in the pathogenesis of asthma. We determined the level of expression of the constitutive (PGHS-1) and inducible (PGHS-2) isoforms of the enzyme in induced sputum and bronchial biopsies of patients with asthma, patients with chronic obstructive pulmonary disease (COPD), and unaffected control subjects by immunocyto- and immunohistochemistry. Immunoreactivity for PGHS-2 was significantly greater in the induced sputum of patients with asthma and patients with COPD compared with unaffected control subjects. The level of PGHS-2 was greater in asthma than in COPD. Immunoreactivity for PGHS-1 increased in cells in the induced sputum of patients with asthma and patients with COPD compared with that of unaffected control subjects. Immunostained cells included macrophages, eosinophils, and neutrophils. Greater PGHS-2 immunoreactivity was seen in the submucosal inflammatory infiltrate and in the airway epithelium of patients with asthma compared with unaffected control subjects. In summary, we demonstrate an induction of PGHS-2 in asthma, suggesting increased formation of prostanoids, which may contribute to the inflammatory process. Taha R, Olivenstein R, Utsumi T, Ernst P, Barnes PJ, Rodger IW, Giaid A. Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease.

This article has been cited by other articles:

				A. J. Duffield-Lillico, J. O. Boyle, X. K. Zhou, A. Ghosh, G. S. Butala, K. Subbaramaiah, R. A. Newman, J. D. Morrow, G. L. Milne, and A. J. Dannenberg Levels of Prostaglandin E Metabolite and Leukotriene E4 Are Increased in the Urine of Smokers: Evidence that Celecoxib Shunts Arachidonic Acid into the 5-Lipoxygenase Pathway Cancer Prevention Research, April 1, 2009; 2(4): 322 - 329. [Abstract] [Full Text] [PDF]

				L. J. Marnett Mechanisms of Cyclooxygenase-2 Inhibition and Cardiovascular Side Effects--The Plot Thickens Cancer Prevention Research, April 1, 2009; 2(4): 288 - 290. [Full Text] [PDF]

				L. Pujols, P. Benitez, I. Alobid, A. Martinez-Anton, J. Roca-Ferrer, J. Mullol, and C. Picado Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo Eur. Respir. J., March 1, 2009; 33(3): 502 - 508. [Abstract] [Full Text] [PDF]

				J. M. Owens, K. R. Shroyer, and T. T. Kingdom Expression of Cyclooxygenase and Lipoxygenase Enzymes in Sinonasal Mucosa of Patients With Cystic Fibrosis Arch Otolaryngol Head Neck Surg, August 1, 2008; 134(8): 825 - 831. [Abstract] [Full Text] [PDF]

				Y. Shiraishi, K. Asano, K. Niimi, K. Fukunaga, M. Wakaki, J. Kagyo, T. Takihara, S. Ueda, T. Nakajima, T. Oguma, et al. Cyclooxygenase-2/Prostaglandin D2/CRTH2 Pathway Mediates Double-Stranded RNA-Induced Enhancement of Allergic Airway Inflammation J. Immunol., January 1, 2008; 180(1): 541 - 549. [Abstract] [Full Text] [PDF]

				J. M. Owens, K. R. Shroyer, and T. T. Kingdom Expression of cyclooxygenase and lipoxygenase enzymes in nasal polyps of aspirin-sensitive and aspirin-tolerant patients. Arch Otolaryngol Head Neck Surg, June 1, 2006; 132(6): 579 - 587. [Abstract] [Full Text] [PDF]

				G. Y. Park and J. W. Christman Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L797 - L805. [Abstract] [Full Text] [PDF]

				C. A. Martey, C. J. Baglole, T. A. Gasiewicz, P. J. Sime, and R. P. Phipps The aryl hydrocarbon receptor is a regulator of cigarette smoke induction of the cyclooxygenase and prostaglandin pathways in human lung fibroblasts Am J Physiol Lung Cell Mol Physiol, September 1, 2005; 289(3): L391 - L399. [Abstract] [Full Text] [PDF]

				P. J. Barnes Mediators of Chronic Obstructive Pulmonary Disease Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548. [Abstract] [Full Text] [PDF]

				T. OGUMA, K. ASANO, T. SHIOMI, K. FUKUNAGA, Y. SUZUKI, M. NAKAMURA, H. MATSUBARA, H. K. SHELDON, K. J. HALEY, C. M. LILLY, et al. Cyclooxygenase-2 Expression during Allergic Inflammation in Guinea-Pig Lungs Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 382 - 386. [Abstract] [Full Text] [PDF]

				Y. Fujitani, Y. Kanaoka, K. Aritake, N. Uodome, K. Okazaki-Hatake, and Y. Urade Pronounced Eosinophilic Lung Inflammation and Th2 Cytokine Release in Human Lipocalin-Type Prostaglandin D Synthase Transgenic Mice J. Immunol., January 1, 2002; 168(1): 443 - 449. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Asthma, Airway Biology, and Allergic Rhinitis in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1559 - 1580. [Full Text] [PDF]

				S. A. KHARITONOV and P. J. BARNES Exhaled Markers of Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722. [Full Text] [PDF]

				L PANG COX-2 expression in asthmatic airways: the story so far Thorax, May 1, 2001; 56(5): 335 - 336. [Full Text]

				A E Redington, Q-H Meng, D R Springall, T J Evans, C Créminon, J Maclouf, S T Holgate, P H Howarth, and J M Polak Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment Thorax, May 1, 2001; 56(5): 351 - 357. [Abstract] [Full Text]